Cargando…

ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years

Obesity and metabolic syndrome are prevalent diseases in children. Circulating leptin, adiponectin, tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and gamma-glutamyl transferase (GGT) are markers associated with cardiometabolic diseases in adults. However, there is a lack of scientific e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mar-Buruato, Ana Marina, Solís-Pérez, Elizabeth, Gonzãlez-Martínez, Blanca Edelia, Lavalle-Gonzãlez, Fernando Javier, Villarreal-Pérez, Jesús Zacarías, Pablo Nuñez-Sãnchez, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625341/
http://dx.doi.org/10.1210/jendso/bvac150.1247
_version_ 1784822470462668800
author Mar-Buruato, Ana Marina
Solís-Pérez, Elizabeth
Gonzãlez-Martínez, Blanca Edelia
Lavalle-Gonzãlez, Fernando Javier
Villarreal-Pérez, Jesús Zacarías
Pablo Nuñez-Sãnchez, Juan
author_facet Mar-Buruato, Ana Marina
Solís-Pérez, Elizabeth
Gonzãlez-Martínez, Blanca Edelia
Lavalle-Gonzãlez, Fernando Javier
Villarreal-Pérez, Jesús Zacarías
Pablo Nuñez-Sãnchez, Juan
author_sort Mar-Buruato, Ana Marina
collection PubMed
description Obesity and metabolic syndrome are prevalent diseases in children. Circulating leptin, adiponectin, tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and gamma-glutamyl transferase (GGT) are markers associated with cardiometabolic diseases in adults. However, there is a lack of scientific evidence in children. Identifying these markers, which are non-invasive, accessible, and allow early detection and treatment of these diseases at an early age, becomes crucial. We examined the association between circulating adipokines and GGT with the metabolic syndrome in Mexican school-age children. The non-probabilistic sample was 140 school children aged 6 to 12 from Nuevo León, México. Nutritional assessment was performed using BMI Z-score from the World Health Organization; the criteria for metabolic syndrome for children and adolescents were from the International Diabetes Federation. Blood samples were obtained by puncturing the antecubital vein with a 12-hour fast. Serum levels of leptin, adiponectin, TNF-α and IL-6 were measured with the Luminex® xMAP® RIA Kit, and the GGT by kinetic reaction with the Dxc Beckman Coulter equipment. A multivariate statistical analysis was carried out to identify the association with the metabolic syndrome, using Student's T-Test and Simple Linear Regression with the IBM SPSS® software. Results,60 children (43%) presented overweight/obesity; 33 obese children were diagnosed with metabolic syndrome (55%). Significant differences were found in leptin (30.61±18.60 vs. 4.14±3.19 ng/mL; P=0. 00), adiponectin (29.54±23.95 vs. 67.71±41.63µg/mL; P=0. 00) and GGT (21.86±13.49 vs. 15. 00±2.69 U/L; P=0. 00), between the groups of children with and without obesity; no significant differences were found between IL-6 (5.11±4.30 vs. 4.26±5.30 pg/mL; P=0.31) and TNF-α (6.64±3.66 vs. 5.94±4.47 pg/mL; P=0.32). In children with or without metabolic syndrome we found significant differences in leptin (32.42±21.39 vs. 10.26±13.11 ng/mL; P=0. 00) and adiponectin (28. 00±19.98vs. 58.55±41.71µg/mL; P=0. 00), between the groups; no significant differences were found between GGT (18.34±7.77 vs. 17.82±10.18 U/L; P=0.78), IL-6 (5.53±4.90 vs. 4.34±4.88 pg/mL; P=0.22) and TNF-α (6.71±4.15 vs. 6. 09±4.15 pg/mL; P=0.46). In the Simple Linear Regression analysis, leptin explains 27% of the variance and adiponectin 10% of the variance. The frequency of overweight and obese children with metabolic syndrome is like other studies (1). The levels of TNF-α and IL-6 did not show a significant association in children with obesity and metabolic syndrome. Leptin and adiponectin are significantly associated with metabolic syndrome in children. In our study GGT is not associated with metabolic syndrome. However, we highlight the importance to continue studying the association of these metabolic markers in clinical practice in children. Reference: (1)López-Jaramillo et al.,Horm Mol BiolClin Invest.2014;18(1): 1–9. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9625341
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96253412022-11-14 ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years Mar-Buruato, Ana Marina Solís-Pérez, Elizabeth Gonzãlez-Martínez, Blanca Edelia Lavalle-Gonzãlez, Fernando Javier Villarreal-Pérez, Jesús Zacarías Pablo Nuñez-Sãnchez, Juan J Endocr Soc Pediatric Endocrinology Obesity and metabolic syndrome are prevalent diseases in children. Circulating leptin, adiponectin, tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and gamma-glutamyl transferase (GGT) are markers associated with cardiometabolic diseases in adults. However, there is a lack of scientific evidence in children. Identifying these markers, which are non-invasive, accessible, and allow early detection and treatment of these diseases at an early age, becomes crucial. We examined the association between circulating adipokines and GGT with the metabolic syndrome in Mexican school-age children. The non-probabilistic sample was 140 school children aged 6 to 12 from Nuevo León, México. Nutritional assessment was performed using BMI Z-score from the World Health Organization; the criteria for metabolic syndrome for children and adolescents were from the International Diabetes Federation. Blood samples were obtained by puncturing the antecubital vein with a 12-hour fast. Serum levels of leptin, adiponectin, TNF-α and IL-6 were measured with the Luminex® xMAP® RIA Kit, and the GGT by kinetic reaction with the Dxc Beckman Coulter equipment. A multivariate statistical analysis was carried out to identify the association with the metabolic syndrome, using Student's T-Test and Simple Linear Regression with the IBM SPSS® software. Results,60 children (43%) presented overweight/obesity; 33 obese children were diagnosed with metabolic syndrome (55%). Significant differences were found in leptin (30.61±18.60 vs. 4.14±3.19 ng/mL; P=0. 00), adiponectin (29.54±23.95 vs. 67.71±41.63µg/mL; P=0. 00) and GGT (21.86±13.49 vs. 15. 00±2.69 U/L; P=0. 00), between the groups of children with and without obesity; no significant differences were found between IL-6 (5.11±4.30 vs. 4.26±5.30 pg/mL; P=0.31) and TNF-α (6.64±3.66 vs. 5.94±4.47 pg/mL; P=0.32). In children with or without metabolic syndrome we found significant differences in leptin (32.42±21.39 vs. 10.26±13.11 ng/mL; P=0. 00) and adiponectin (28. 00±19.98vs. 58.55±41.71µg/mL; P=0. 00), between the groups; no significant differences were found between GGT (18.34±7.77 vs. 17.82±10.18 U/L; P=0.78), IL-6 (5.53±4.90 vs. 4.34±4.88 pg/mL; P=0.22) and TNF-α (6.71±4.15 vs. 6. 09±4.15 pg/mL; P=0.46). In the Simple Linear Regression analysis, leptin explains 27% of the variance and adiponectin 10% of the variance. The frequency of overweight and obese children with metabolic syndrome is like other studies (1). The levels of TNF-α and IL-6 did not show a significant association in children with obesity and metabolic syndrome. Leptin and adiponectin are significantly associated with metabolic syndrome in children. In our study GGT is not associated with metabolic syndrome. However, we highlight the importance to continue studying the association of these metabolic markers in clinical practice in children. Reference: (1)López-Jaramillo et al.,Horm Mol BiolClin Invest.2014;18(1): 1–9. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9625341/ http://dx.doi.org/10.1210/jendso/bvac150.1247 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Mar-Buruato, Ana Marina
Solís-Pérez, Elizabeth
Gonzãlez-Martínez, Blanca Edelia
Lavalle-Gonzãlez, Fernando Javier
Villarreal-Pérez, Jesús Zacarías
Pablo Nuñez-Sãnchez, Juan
ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years
title ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years
title_full ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years
title_fullStr ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years
title_full_unstemmed ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years
title_short ODP382 Circulating Adipokines and Gamma-Glutamyl Transferase As Markers Associated With Metabolic Syndrome in Mexican Children Aged 6 to 12 Years
title_sort odp382 circulating adipokines and gamma-glutamyl transferase as markers associated with metabolic syndrome in mexican children aged 6 to 12 years
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625341/
http://dx.doi.org/10.1210/jendso/bvac150.1247
work_keys_str_mv AT marburuatoanamarina odp382circulatingadipokinesandgammaglutamyltransferaseasmarkersassociatedwithmetabolicsyndromeinmexicanchildrenaged6to12years
AT solisperezelizabeth odp382circulatingadipokinesandgammaglutamyltransferaseasmarkersassociatedwithmetabolicsyndromeinmexicanchildrenaged6to12years
AT gonzalezmartinezblancaedelia odp382circulatingadipokinesandgammaglutamyltransferaseasmarkersassociatedwithmetabolicsyndromeinmexicanchildrenaged6to12years
AT lavallegonzalezfernandojavier odp382circulatingadipokinesandgammaglutamyltransferaseasmarkersassociatedwithmetabolicsyndromeinmexicanchildrenaged6to12years
AT villarrealperezjesuszacarias odp382circulatingadipokinesandgammaglutamyltransferaseasmarkersassociatedwithmetabolicsyndromeinmexicanchildrenaged6to12years
AT pablonunezsanchezjuan odp382circulatingadipokinesandgammaglutamyltransferaseasmarkersassociatedwithmetabolicsyndromeinmexicanchildrenaged6to12years